Guardant Health Inc (NASDAQ: GH) kicked off on Friday, up 3.09% from the previous trading day, before settling in for the closing price of $44.72. Over the past 52 weeks, GH has traded in a range of $15.81-$50.89.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 28.17% over the last five years. While this was happening, its average annual earnings per share was recorded 19.11%. With a float of $118.00 million, this company’s outstanding shares have now reached $123.99 million.
The firm has a total of 2021 workers. Let’s measure their productivity. In terms of profitability, gross margin is 60.79%, operating margin of -60.02%, and the pretax margin is -58.87%.
Guardant Health Inc (GH) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Diagnostics & Research Industry. The insider ownership of Guardant Health Inc is 4.39%, while institutional ownership is 96.26%. The most recent insider transaction that took place on Mar 19 ’25, was worth 5,069. In this transaction Director of this company sold 116 shares at a rate of $43.70, taking the stock ownership to the 3,211 shares. Before that another transaction happened on Mar 19 ’25, when Company’s Director proposed sale 116 for $43.70, making the entire transaction worth $5,069.
Guardant Health Inc (GH) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 19.11% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 17.42% during the next five years compared to -33.61% drop over the previous five years of trading.
Guardant Health Inc (NASDAQ: GH) Trading Performance Indicators
Take a look at Guardant Health Inc’s (GH) current performance indicators. Last quarter, stock had a quick ratio of 4.36. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.56, a number that is poised to hit -0.75 in the next quarter and is forecasted to reach -2.45 in one year’s time.
Technical Analysis of Guardant Health Inc (GH)
Analysing the last 5-days average volume posted by the [Guardant Health Inc, GH], we can find that recorded value of 2.04 million was lower than the volume posted last year of 2.49 million. As of the previous 9 days, the stock’s Stochastic %D was 89.40%. Additionally, its Average True Range was 3.07.
During the past 100 days, Guardant Health Inc’s (GH) raw stochastic average was set at 84.42%, which indicates a significant decrease from 93.19% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 98.97% in the past 14 days, which was higher than the 73.77% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $43.62, while its 200-day Moving Average is $32.33. Now, the first resistance to watch is $47.16. This is followed by the second major resistance level at $48.21. The third major resistance level sits at $50.04. If the price goes on to break the first support level at $44.27, it is likely to go to the next support level at $42.44. Should the price break the second support level, the third support level stands at $41.39.
Guardant Health Inc (NASDAQ: GH) Key Stats
The company with the Market Capitalisation of 5.69 billion has total of 123,421K Shares Outstanding. Its annual sales at the moment are 739,020 K in contrast with the sum of -436,370 K annual income. Company’s last quarter sales were recorded 201,810 K and last quarter income was -111,010 K.
